Status:
COMPLETED
Long-term Follow-up Prognosis of Atrophic Gastritis After 3 Years
Lead Sponsor:
Konkuk University Medical Center
Conditions:
Gastric Neoplasm
Gastric Cancer
Eligibility:
All Genders
18-90 years
Brief Summary
Serum pepsinogen (PG) levels are considered reliable markers for progression of atrophic gastritis with a stepwise reduction in the serum PG I level or PG I/II ratio. A combination of serum PG levels ...
Detailed Description
According to the Correa's hypothesis, the combination method using serum pepsinogen levels and serum Helicobacter pylori antibody would predict the risk and cell type of gastric neoplasm. However, in ...
Eligibility Criteria
Inclusion
- Korean adults older than 18 year-old
- Subjects who agreed on serum pepsinogen tests, H. pylori serology, and upper gastrointestinal endoscopy on the same day
Exclusion
- Subjects who had past history of gastric surgery
- Abnormal endoscopic or laboratory finding that require further treatment
- Any evidence of malignancy other than gastric neoplasm
Key Trial Info
Start Date :
January 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2013
Estimated Enrollment :
3328 Patients enrolled
Trial Details
Trial ID
NCT01824953
Start Date
January 1 2010
End Date
August 1 2013
Last Update
August 16 2013
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Konkuk University Medical Center
Seoul, South Korea, 143-729
2
Konkuk University Medical Center
Seoul, South Korea